Seth Apter

721 total citations
17 papers, 573 citations indexed

About

Seth Apter is a scholar working on Psychiatry and Mental health, Clinical Psychology and Social Psychology. According to data from OpenAlex, Seth Apter has authored 17 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 4 papers in Clinical Psychology and 3 papers in Social Psychology. Recurrent topics in Seth Apter's work include Schizophrenia research and treatment (12 papers), Tryptophan and brain disorders (3 papers) and Mental Health and Psychiatry (3 papers). Seth Apter is often cited by papers focused on Schizophrenia research and treatment (12 papers), Tryptophan and brain disorders (3 papers) and Mental Health and Psychiatry (3 papers). Seth Apter collaborates with scholars based in United States and Netherlands. Seth Apter's co-authors include Michael Davidson, L.J. Siever, Richard C. Mohs, Michael Davidson, Thomas Horvath, Emil F. Coccaro, Kenneth L. Davis, Jack Hirschowitz, James Schmeidler and Philip D. Harvey and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Schizophrenia Bulletin.

In The Last Decade

Seth Apter

16 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seth Apter United States 11 407 220 142 101 92 17 573
W T Carpenter United States 8 555 1.4× 172 0.8× 207 1.5× 167 1.7× 58 0.6× 10 733
Yasuhito Ishimoto Japan 9 357 0.9× 114 0.5× 108 0.8× 167 1.7× 79 0.9× 13 525
Clifford Widmark United States 5 461 1.1× 171 0.8× 143 1.0× 142 1.4× 131 1.4× 6 626
Sarah I. Tarbox United States 13 484 1.2× 233 1.1× 167 1.2× 131 1.3× 35 0.4× 15 629
M. Obuchowski United States 6 444 1.1× 169 0.8× 175 1.2× 175 1.7× 40 0.4× 9 542
Evelyn Howanitz United States 8 465 1.1× 90 0.4× 148 1.0× 168 1.7× 97 1.1× 12 612
Huma Saeedi Canada 7 589 1.4× 235 1.1× 255 1.8× 186 1.8× 46 0.5× 7 730
Stan Mutsatsa United Kingdom 6 374 0.9× 108 0.5× 90 0.6× 165 1.6× 49 0.5× 6 507
Boris Rauchverger Israel 4 232 0.6× 192 0.9× 33 0.2× 104 1.0× 80 0.9× 5 378
J Dennert United States 6 446 1.1× 72 0.3× 111 0.8× 268 2.7× 63 0.7× 9 612

Countries citing papers authored by Seth Apter

Since Specialization
Citations

This map shows the geographic impact of Seth Apter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth Apter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth Apter more than expected).

Fields of papers citing papers by Seth Apter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seth Apter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth Apter. The network helps show where Seth Apter may publish in the future.

Co-authorship network of co-authors of Seth Apter

This figure shows the co-authorship network connecting the top 25 collaborators of Seth Apter. A scholar is included among the top collaborators of Seth Apter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seth Apter. Seth Apter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Keefe, R.S.E., et al.. (1996). Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings. American Journal of Psychiatry. 153(6). 806–811. 47 indexed citations
2.
Trestman, Robert L., Thomas Horvath, Oren Kalus, et al.. (1996). Event-related potentials in schizotypal personality disorder. Journal of Neuropsychiatry. 8(1). 33–40. 44 indexed citations
3.
Siever, Larry J., Merrill Rotter, Miklos Losonczy, et al.. (1995). Lateral ventricular enlargement in schizotypal personality disorder. Psychiatry Research. 57(2). 109–118. 26 indexed citations
4.
Davidson, Michael, René S. Kahn, James Schmeidler, et al.. (1995). Assessment of the Central Dopaminergic Index of Plasma HVA in Schizophrenia. Schizophrenia Bulletin. 21(1). 53–66. 41 indexed citations
5.
Stern, Robert G., et al.. (1993). Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia. Psychiatry Research. 46(2). 151–163. 39 indexed citations
6.
Stern, Robert G., RenéS. Kahn, Philip D. Harvey, et al.. (1993). Early response to haloperidol treatment in chronic schizophrenia. Schizophrenia Research. 10(2). 165–171. 31 indexed citations
7.
Silverman, J. M., L.J. Siever, Thomas Horvath, et al.. (1993). Schizophrenia-related and affective personality disorder traits in relatives of probands with schizophrenia and personality disorders. American Journal of Psychiatry. 150(3). 435–442. 43 indexed citations
8.
Kahn, R.S., Michael Davidson, L.J. Siever, et al.. (1993). Serotonin function and treatment response to clozapine in schizophrenic patients. American Journal of Psychiatry. 150(9). 1337–1342. 56 indexed citations
9.
Keefe, Richard S.E., Philip D. Harvey, Mark F. Lenzenweger, et al.. (1992). Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: Negative symptoms. Psychiatry Research. 44(2). 153–165. 92 indexed citations
10.
Kahn, RenéS., Larry J. Siever, Farooq Amin, et al.. (1992). Serotonin function in schizophrenia: Effects of meta- chlorophenylpiperazine in schizophrenia patients and healthy subjects. Psychiatry Research. 43(1). 1–12. 40 indexed citations
11.
Stern, Robert G., René S. Kahn, Michael Davidson, et al.. (1992). Significant decrease in psychopathology within three days of haloperidol treatment in chronic schizophrenia. Schizophrenia Research. 6(2). 109–110. 1 indexed citations
12.
Kahn, R.S., Steven M. Gabriel, Kimberly DuMont, et al.. (1991). Serotonin receptor sensitivity in schizophrenia. Schizophrenia Research. 4(3). 347–348. 1 indexed citations
13.
Frecska, Ede, Miklos Losonczy, R.S.E. Keefe, et al.. (1991). Kraepelinian schizophrenia: A replication in an independent sample. Schizophrenia Research. 4(3). 257–257. 1 indexed citations
14.
Silverman, J. M., Thomas Horvath, Emil F. Coccaro, et al.. (1991). Affective and impulsive personality disorder traits in the relatives of patients with borderline personality disorder. American Journal of Psychiatry. 148(10). 1378–1385. 106 indexed citations
15.
Kahn, R.S., et al.. (1991). Plasma homovanillic acid concentrations decrease in responders, but not in non-responders, to neuroleptic treatment. Schizophrenia Research. 4(3). 347–347. 2 indexed citations
16.
Amin, Farooq, et al.. (1990). Increments in plasma homovanillic acid concentrations after neuroleptic discontinuation are associated with worsening of schizophrenic symptoms. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 14(6). 879–884. 2 indexed citations
17.
Sackeïm, Harold A., Isak Prohovnik, James R. Moeller, et al.. (1989). An abnormal cortical neural network in major depression. Biological Psychiatry. 25(7). A157–A158. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026